经口机器人手术治疗口咽癌:手术切缘与肿瘤学结局
5年局部区域无复发生存率92%、无远处转移生存率90%、总生存率86%、癌症特异性生存率94%,98%病例实现阴性切缘。需取≥2次切缘才能达到切除与局部区域复发和疾病死亡风险增加相关。
要点
- TORS治疗口咽鳞癌可获得98%阴性切缘及良好5年生存。
- 需≥2次切缘才达到切除提示局部区域复发和死亡风险增加。
- ACE-27合并症指数、HPV状态、病理N分期及切缘尝试次数与癌症死亡相关。
核心结论
- TORS±辅助治疗口咽鳞癌的5年肿瘤学结局良好。
- 需取≥2次切缘才能实现切除预示局部区域复发和疾病死亡风险增加。
研究设计与样本
- 中位随访3.3年(四分位距1.8-5.3年;范围1天至9.3年)。
主要发现
- 5年局部区域无复发生存率92%(95%CI 88-95;仍有风险人数92)。
- 5年无远处转移生存率90%(95%CI 86-94;仍有风险人数92)。
- 5年总生存率86%(95%CI 82-92;仍有风险人数98)。
- 5年癌症特异性生存率94%(95%CI 91-97;仍有风险人数98)。
- 98%病例实现阴性切缘。
临床怎么用
- TORS可作为口咽鳞癌的手术选择,多数病例可实现阴性切缘。
- 术中需多次切缘才能达到阴性时应警惕局部区域复发和疾病死亡风险。
- ACE-27合并症指数、HPV状态和病理N分期可用于风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study presents oncologic outcomes after transoral robotic surgery (TORS) ± adjuvant therapy for oropharyngeal squamous cell carcinoma (SCC). METHODS: Three hundred fourteen patients undergoing TORS ± adjuvant therapy for oropharyngeal SCC from May 1, 2007, to May 31, 2015, are analyzed. RESULTS: Median follow-up was 3.3 years (interquartile range [IQR] 1.8-5.3 years; range 1 day to 9.3 years). Estimated locoregional recurrence-free survival, distant metastasis-free survival (DMFS), overall survival (OS), and cancer-specific survival (CSS) rates (95% confidence interval [CI] number still at risk) at 5 years after surgery were 92% (88-95; 92), 90% (86-94; 92), 86% (82-92; 98), and 94% (91-97; 98), respectively. Negative margins were achieved in 98% of cases. The adult comorbidity evaluation (ACE)-27 comorbidity index, human papillomavirus (HPV) status, pathologic N classification, and number of attempts to clear margins were associated with death due to cancer (P = .003, P = .002, P = .030, and P = .002, respectively). CONCLUSION: The need to take ≥2 margins to achieve resection portends an increased risk of locoregional recurrence and death due to disease in oropharyngeal SCC.
引用
- Moore EJ, Van Abel KM, Price DL, et al. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes. Head Neck. 2018. PMID: 29327784. doi:10.1002/hed.25055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。